Make Kitco Your Homepage

MindMed enters digital medicine space with HealthMode acquisition

Kitco News

MindMed (MMED.NE) has announced the acquisition of HealthMode, which now gives the company access to artificial intelligence-enabled clinical research.

The $41.6 million all-share transaction gives MindMed control of HealthMode’s intellectual property, as well as a new team.

“Today is going to give a whole new trajectory to MindMed. Before, we were very much looked at as a pure-play biotech company focused on the psychedelic medicine space. I think today, we now are a half software company. In terms of headcount, we added 24 machine learning and product engineers. If you look back a year from now, you will look back at MindMed as much a tech company as it is a drug development company,” said JR Rahn, co-founder and CEO.

Disclaimer: The views expressed in this article are those of the author and may not reflect those of Kitco Metals Inc. The author has made every effort to ensure accuracy of information provided; however, neither Kitco Metals Inc. nor the author can guarantee such accuracy. This article is strictly for informational purposes only. It is not a solicitation to make any exchange in commodities, securities or other financial instruments. Kitco Metals Inc. and the author of this article do not accept culpability for losses and/ or damages arising from the use of this publication.